Two new patents for Implemed's technology:
This article was originally published in Clinica
Implemed has received two additional US patents relating to its antimicrobial polymer technology. Used to develop anti-infective medical devices, the technology, known as Oligon, is based on a process called oligodynamic iontopheresis whereby silver ions are released to destroy microbes on the surface of a device. Implemed's first product using the technology, the Olimpicc peripherally inserted central venous catheter, is sold in Europe. The Watertown, Massachusetts-based company plans to develop partnerships and licensing opportunities to use its technology in a broader spectrum of medical devices.